中国人群HLA I类与自身免疫性糖尿病的关联:经典型1型糖尿病与LADA的不同意义
该病例对照研究对1067例经典型1型糖尿病、1062例成人隐匿性自身免疫糖尿病(LADA)及1107名正常对照进行HLA-A、-B、-C、-DRB1、-DQA1和-DQB1位点下一代测序,发现HLA I类等位基因对经典型1型糖尿病和LADA的风险及临床特征影响不同,LADA的HLA I类易感性减弱。
要点
- 经典型1型糖尿病与LADA共享4个HLA I类等位基因,但7个等位基因仅增加经典型1型糖尿病风险。
- 仅A*02:01为LADA的额外风险因素,LADA的HLA I类易感性较经典型1型糖尿病减弱。
- HLA I类等位基因影响经典型1型糖尿病多项临床特征,但对LADA临床特征影响有限。
核心结论
- LADA的HLA I类易感性减弱,提示其免疫遗传学危害性较经典型1型糖尿病轻。
- 自身免疫糖尿病相关HLA I类变异可能作为中国人群未来筛查的附加标志物。
研究设计与样本
- 病例对照研究,纳入1067例经典型1型糖尿病、1062例LADA和1107名正常对照。
- 采用下一代测序获取HLA-A、-B、-C、-DRB1、-DQA1和-DQB1位点基因型。
主要发现
- 经典型1型糖尿病与LADA共享4个等位基因:保护性A*02:07和B*46:01,易感性B*54:01和C*08:01。
- 7个I类等位基因仅增加经典型1型糖尿病风险:A*24:02、B*15:02、B*15:18、B*39:01、B*40:06、B*48:01和C*07:02。
- 仅A*02:01为LADA的额外风险因素。
- I类等位基因影响经典型1型糖尿病多项临床特征,包括蛋白酪氨酸磷酸酶自身抗体和锌转运体8自身抗体阳性率(A*24:02)、C肽水平(A*24:02)及诊断年龄(B*46:01、C*01:02、B*15:02、C*07:02和C*08:01)。
- 除C*08:01对LADA的C肽浓度有不利影响外,未报告其他I类等位基因与LADA临床特征的关联。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: We aimed to investigate whether human leukocyte antigen (HLA) Class I loci differentially modulated the risk for and clinical features of Chinese people with classic type 1 diabetes (T1D) and latent autoimmune diabetes in adults (LADA). METHODS: In this case-control study, genotypes of HLA-A, -B, -C, -DRB1, -DQA1, and -DQB1 loci were obtained from 1067 cases with classic T1D, 1062 cases with LADA, and 1107 normal controls using next-generation sequencing. RESULTS: Despite 4 alleles shared between classic T1D and LADA (protective: A*02:07 and B*46:01; susceptible: B*54:01 and C*08:01), 7 Class I alleles conferred risk exclusively for classic T1D (A*24:02, B*15:02, B*15:18, B*39:01, B*40:06, B*48:01, and C*07:02) whereas only A*02:01 was an additional risk factor for LADA. Class I alleles affected a wide spectrum of T1D clinical features, including positive rate of protein tyrosine phosphatase autoantibody and zinc transporter 8 autoantibody (A*24:02), C-peptide levels (A*24:02), and age at diagnosis (B*46:01, C*01:02, B*15:02, C*07:02, and C*08:01). By contrast, except for the detrimental effect of C*08:01 on C-peptide concentrations in LADA, no other Class I associations with clinical characteristics of LADA could be reported. The addition of Class I alleles refined the risk model consisting only of DR-DQ data in classic T1D while the overall predictive value of the LADA risk model comprising both Class I and II information was relatively low. CONCLUSION: The attenuated HLA Class I susceptibility to LADA was indicative of a less deleterious immunogenetic nature compared with classic T1D. These autoimmune diabetes-related Class I variants might serve as additional markers in future screening among Chinese people.
引用
- Xia Y, Chen Y, Li X, et al. HLA Class I Association With Autoimmune Diabetes in Chinese People: Distinct Implications in Classic Type 1 Diabetes and LADA. J Clin Endocrinol Metab. 2023. PMID: 36652403. doi:10.1210/clinem/dgad006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。